We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$118M
This Fund
S&P 500
This Quarter
Est. Return
+9.75%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$135M
AUM Growth
-$1.28M
(-0.95%)
Cap. Flow
-$11.4M
Cap. Flow
% of AUM
-8.5%
Top 10 Holdings %
Top 10 Hldgs %
21.49%
Holding
245
New
28
Increased
29
Reduced
140
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$2.85M |
| 2 |
Alphatec Holdings
ATEC
|
+$2.84M |
| 3 |
Indivior Pharmaceuticals
INDV
|
+$2.84M |
| 4 |
Neurocrine Biosciences
NBIX
|
+$2.12M |
| 5 |
APLS
Apellis Pharmaceuticals
APLS
|
+$1.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioCryst Pharmaceuticals
BCRX
|
+$4.17M |
| 2 |
Pacira BioSciences
PCRX
|
+$3.36M |
| 3 |
Pfizer
PFE
|
+$3.06M |
| 4 |
United Therapeutics
UTHR
|
+$2.79M |
| 5 |
uniQure
QURE
|
+$2.06M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 57.92% |
| 2 | Real Estate | 14.45% |
| 3 | Financials | 7.05% |
| 4 | Industrials | 3.2% |
| 5 | Technology | 2.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Ford
F
$57.3B
| $83.4K | 0.06% |
7,900
-185
| -2% | -$2.12K |
|
202
Diamondback Energy
FANG
$57.6B
| $82.6K | 0.06% |
479
-13
| -3% | -$2.5K |
|
203
Reinsurance Group of America
RGA
$15.7B
| $82.4K | 0.06% |
378
-9
| -2% | -$1.91K |
|
204
Prudential Financial
PRU
$41.7B
| $81.1K | 0.06% |
670
-11
| -2% | -$1.3K |
|
205
Celanese
CE
$5.09B
| $80.4K | 0.06% |
591
-20
| -3% | -$2.63K |
|
206
Cardinal Health
CAH
$53.4B
| $72.9K | 0.05% |
660
-15
| -2% | -$1.57K |
|
207
Charter Communications
CHTR
$14.7B
| $72.9K | 0.05% |
225
-8
| -3% | -$2.69K |
|
208
Norwegian Cruise Line
NCLH
$8.89B
| $65.9K | 0.05% |
3,214
-90
| -3% | -$1.63K |
|
209
iShares MSCI South Korea ETF
EWY
$21.7B
| $63.6K | 0.05% |
995
-785
| -44% | -$50.8K |
|
210
MGM Resorts International
MGM
$11.7B
| $59.3K | 0.04% |
1,518
-42
| -3% | -$1.66K |
|
211
GXO Logistics
GXO
$6.06B
| $55.6K | 0.04% |
1,068
-29
| -3% | -$1.47K |
|
212
Duolingo
DUOL
$5.7B
| $55K | 0.04% |
195
-6
| -3% | -$1.23K |
|
213
Arista Networks
ANET
$219B
| $53.4K | 0.04% |
556
-16
| -3% | -$1.39K |
|
214
DoorDash
DASH
$75.3B
| $46K | 0.03% |
322
-9
| -3% | -$1.09K |
|
215
Howmet Aerospace
HWM
$116B
| $45.6K | 0.03% |
455
-13
| -3% | -$1.17K |
|
216
Broadcom
AVGO
$1.82T
| $44.7K | 0.03% |
259
-11
| -4% | -$1.76K |
|
217
Warner Bros
WBD
$64.6B
| $44K | 0.03% |
5,338
-149
| -3% | -$1.16K |
|
218
Mercado Libre
MELI
$91.3B
| $43.1K | 0.03% |
21
| – | – |
|
219
iShares MSCI Chile ETF
ECH
$1.01B
| $42.4K | 0.03% |
1,556
+111
| +8% | +$2.9K |
|
220
CG Oncology
CGON
$6.11B
| $37.7K | 0.03% |
1,000
| – | – |
|
221
Woodward
WWD
$25B
| $36K | 0.03% |
210
-5
| -2% | -$832 |
|
222
HubSpot
HUBS
$10.5B
| $31.4K | 0.02% |
59
-1
| -2% | -$502 |
|
223
Datadog
DDOG
$87.9B
| $30.7K | 0.02% |
267
-7
| -3% | -$818 |
|
224
CrowdStrike
CRWD
$187B
| $27.8K | 0.02% |
396
-8
| -2% | -$568 |
|
225
Elastic
ESTC
$6.1B
| $26K | 0.02% |
339
-10
| -3% | -$986 |
|
Similar funds
AIS
IVGAI
OIM
TIP
RCG
CWM
SPW
WLC
AlphaCentric Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, AlphaCentric Advisors held 245 positions worth $135M, down 0.95% from $136M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
AlphaCentric Advisors withdrew a net $11.4M in Q3 2024, closing 15 positions and reducing 140 holdings. Its most notable exit was BioCryst Pharmaceuticals, an estimated $4.17M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 58% of assets, down from 60% a quarter earlier, followed by Real Estate and Financials.
Against the trend, AlphaCentric Advisors opened a new position in Merck worth $2.73M.
- AlphaCentric Advisors's largest Q3 2024 buy was Merck: 24,000 shares worth $2.73M.
- AlphaCentric Advisors added most to Neurocrine Biosciences in Q3 2024, an estimated $2.12M increase.
- AlphaCentric Advisors's biggest Q3 2024 reduction was Pfizer, cutting an estimated $3.06M.
- AlphaCentric Advisors fully exited BioCryst Pharmaceuticals in Q3 2024, selling an estimated $4.17M.
- AlphaCentric Advisors's ten largest holdings make up 21% of its $135M portfolio in Q3 2024.
- AlphaCentric Advisors opened 28 new positions and closed 15 in Q3 2024.
- AlphaCentric Advisors's portfolio value fell 0.95% quarter-over-quarter to $135M.
Based on AlphaCentric Advisors's 13F filing for Q3 2024, filed 30 Oct 2024.